What is Celcuity Inc.'s earnings per share (EPS)?

Celcuity Inc. (CELC) reported diluted earnings per share of -$3.79 for fiscal year 2025. This represents a -33.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Celcuity Inc. (CELC) Financials

CELC

FY2025 annual

Net Income -$177.0M -58.4% YoY

EPS (Diluted) -$3.79 -33.9% YoY

Free Cash Flow -$153.5M -83.4% YoY

Operating Cash Flow -$153.3M -83.6% YoY

Market Cap $3.1B as of Oct 13, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CELC SEC filings page.

This page shows Celcuity Inc. (CELC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CELC FY2025 2026-10-04

Celcuity operates as a development-stage business funded increasingly by external capital while research spending and cash outflows accelerate.

Between FY2023 and FY2025, R&D more than doubled to $145.0M while operating cash outflow reached $153.3M, showing the development program is consuming cash at roughly its spending scale. Because FY2025 financing cash inflow was $360.6M, that expansion is being funded externally rather than by internally generated cash.

The balance sheet has shifted toward debt-dependent financing: debt-to-equity reached 1.4x in FY2025 as equity fell. Total liabilities reached $366.0M against $100.6M of equity, so financial claims now materially exceed shareholders’ accounting cushion.

Reported liquidity equaled 34.6 months of the latest annual operating outflow, a historical balance-sheet comparison rather than a projection. FY2025 free cash flow was -$153.5M versus operating cash flow of -$153.3M, indicating that capital expenditures were not the main reason cash use remained elevated.

Financial Health Signals

Financial health score not available

Celcuity Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/7

Celcuity Inc. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

Celcuity Inc. reported a net loss of $177.0M while operations used $153.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Celcuity Inc. reported an operating loss of $172.2M against $14.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$66.1M

YoY-50.2%

QoQ-30.9%

Celcuity Inc.'s EBITDA was -$66.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 50.2% from the same quarter a year earlier. Against the prior quarter it is down 30.9%.

Net Income

-$78.9M

YoY-74.2%

QoQ-49.2%

Celcuity Inc. reported -$78.9M in net income in Q2 2026. This represents a decrease of 74.2% from the same quarter a year earlier. Against the prior quarter it is down 49.2%.

EPS (Diluted)

-$1.44

YoY-38.5%

QoQ-48.5%

Celcuity Inc. earned -$1.44 per diluted share (EPS) in Q2 2026. This represents a decrease of 38.5% from the same quarter a year earlier. Against the prior quarter it is down 48.5%.

Revenue

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

-$55.5M

YoY-53.0%

QoQ-0.3%

Celcuity Inc. recorded an outflow of $55.5M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 53.0% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.

Cash & Debt

$182.0M

YoY+292.7%

QoQ+25.4%

5Y CAGR+34.3%

Celcuity Inc. held $182.0M in cash against $0 in long-term debt as of Q2 2026.

Shares Outstanding

49M

YoY+15.3%

QoQ+0.3%

5Y CAGR+26.8%

Celcuity Inc. had 49M shares outstanding in Q2 2026. This represents an increase of 15.3% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

R&D Spending

$31.1M

YoY-14.7%

QoQ-6.0%

Celcuity Inc. invested $31.1M in research and development in Q2 2026. This represents a decrease of 14.7% from the same quarter a year earlier. Against the prior quarter it is down 6.0%.

Capital Expenditures

$51K

YoY+30.8%

QoQ-79.5%

5Y CAGR+13.6%

Celcuity Inc. invested $51K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 30.8% from the same quarter a year earlier. Against the prior quarter it is down 79.5%.

Share Buybacks

Not reported for Q2 2026.

CELC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CELC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
R&D Expenses	N/A	$145.0M+39.1%	$104.2M+72.0%	$60.6M+71.7%	$35.3M+37.0%	$25.8M+235.2%	$7.7M+22.6%	$6.3M-0.9%	$6.3M+27.0%	$5.0M+62.5%	$3.1M
SG&A Expenses	N/A	$27.2M+200.1%	$9.1M+60.8%	$5.6M+37.4%	$4.1M+57.9%	$2.6M+38.7%	$1.9M+21.9%	$1.5M-4.4%	$1.6M+65.2%	$973K+268.8%	$264K
Operating Income	N/A	-$172.2M-52.0%	-$113.3M-71.0%	-$66.2M-68.1%	-$39.4M-38.9%	-$28.4M-196.7%	-$9.6M-22.4%	-$7.8M+1.6%	-$7.9M-33.3%	-$6.0M-78.9%	-$3.3M
EBITDA	N/A	-$172.0M-52.1%	-$113.1M-71.2%	-$66.1M-68.7%	-$39.2M-39.7%	-$28.0M-206.0%	-$9.2M-22.8%	-$7.5M+3.2%	-$7.7M-31.8%	-$5.8M-79.6%	-$3.3M
Interest Expense	N/A	$14.4M+39.8%	$10.3M+93.4%	$5.3M+152.9%	$2.1M+66.8%	$1.3M+1051858.3%	$120-24.5%	$159+43.2%	$111-100.0%	$452K	$0
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0
Net Income	N/A	-$177.0M-58.4%	-$111.8M-75.3%	-$63.8M-58.0%	-$40.4M-36.4%	-$29.6M-212.5%	-$9.5M-28.7%	-$7.4M+1.6%	-$7.5M-19.7%	-$6.3M-88.9%	-$3.3M
EPS (Basic)	N/A	-$3.79-33.9%	-$2.83-5.2%	-$2.69-1.9%	-$2.64-19.5%	-$2.21	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$4.31	-$3.79-33.9%	-$2.83	-$2.69	-$2.64	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	47M+18.5%	39M	24M	15M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
R&D Expenses	$31.1M-14.7%	$33.1M+11.1%	N/A	$34.9M+26.6%	$36.4M+61.9%	$29.8M+44.1%	N/A	$27.6M+57.8%
SG&A Expenses	$35.0M+361.4%	$17.4M+173.7%	N/A	$7.9M+221.0%	$7.6M+325.2%	$6.4M+245.3%	N/A	$2.5M+75.3%
Operating Income	-$66.1M-50.2%	-$50.5M-39.8%	N/A	-$42.8M-42.5%	-$44.0M-81.2%	-$36.1M-60.6%	N/A	-$30.1M-59.1%
EBITDA	-$66.1M-50.2%	-$50.5M-39.8%	N/A	-$42.8M-42.6%	-$44.0M-81.3%	-$36.1M-60.7%	N/A	-$30.0M-59.2%
Interest Expense	$3.5M+9.4%	$4.5M+40.6%	N/A	$4.6M+37.4%	$3.2M+41.6%	$3.2M+128.5%	N/A	$3.3M+143.7%
Net Income	-$78.9M-74.2%	-$52.8M-42.8%	N/A	-$43.8M-47.0%	-$45.3M-90.8%	-$37.0M-71.2%	N/A	-$29.8M-61.9%
EPS (Basic)	-$1.44-38.5%	-$0.97-12.8%	-$0.98-12.6%	-$0.92-31.4%	-$1.04-67.7%	-$0.86-34.4%	-$0.87-35.9%	-$0.70+15.7%
EPS (Diluted)	-$1.44-38.5%	-$0.97-12.8%	-$0.98-12.6%	-$0.92-31.4%	-$1.04-67.7%	-$0.86-34.4%	-$0.87-35.9%	-$0.70
Diluted Shares (Avg)	55M+25.5%	54M+26.5%	N/A	48M+11.2%	44M+13.6%	43M+28.1%	N/A	43M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.

CELC Balance Sheet

CELC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Total Assets	$466.6M+90.3%	$245.1M+28.2%	$191.2M+8.8%	$175.7M+104.5%	$85.9M+563.0%	$13.0M-36.1%	$20.3M-22.1%	$26.0M-18.6%	$32.0M+427.8%	$6.1M
Current Assets	$465.7M+90.4%	$244.6M+28.3%	$190.6M+8.8%	$175.2M+105.3%	$85.4M+601.5%	$12.2M-36.8%	$19.3M-23.7%	$25.2M+3.0%	$24.5M+314.1%	$5.9M
Cash & Equivalents	$165.7M+636.0%	$22.5M-26.6%	$30.7M+24.8%	$24.6M-70.8%	$84.3M+624.2%	$11.6M-37.9%	$18.7M+17.5%	$15.9M+492.8%	$2.7M-54.1%	$5.9M
Short-Term Investments	$275.8M+29.7%	$212.6M+41.8%	$149.9M+4.1%	$144.0M	$0	$0	$0-100.0%	$9.0M-58.5%	$21.6M	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$7.2M	$0
Total Liabilities	$366.0M+182.6%	$129.5M+151.7%	$51.5M+22.7%	$41.9M+143.8%	$17.2M+1270.8%	$1.3M+27.6%	$983K+44.1%	$682K+18.0%	$578K+29.8%	$445K
Current Liabilities	$44.2M+39.2%	$31.7M+123.6%	$14.2M+106.2%	$6.9M+174.6%	$2.5M+111.4%	$1.2M+30.1%	$911K+37.6%	$662K+14.6%	$578K+29.8%	$445K
Non-Current Liabilities	$321.9M+229.2%	$97.8M+162.4%	$37.3M+6.3%	$35.0M+138.6%	$14.7M+21140.8%	$69K-3.8%	$72K+261.7%	$20K	$0	$0
Long-Term Debt	$137.5M+30.9%	$105.1M+179.8%	$37.6M+5.1%	$35.8M+123.8%	$16.0M	N/A	N/A	N/A	N/A	N/A
Total Equity	$100.6M-13.0%	$115.6M-17.3%	$139.8M+4.5%	$133.8M+94.7%	$68.7M+487.2%	$11.7M-39.4%	$19.3M-23.9%	$25.3M-19.2%	$31.4M+459.4%	$5.6M
Retained Earnings	-$448.9M-65.1%	-$271.9M-69.8%	-$160.1M-66.2%	-$96.3M-72.2%	-$55.9M-112.5%	-$26.3M-56.2%	-$16.8M-77.6%	-$9.5M-372.7%	-$2.0M+75.9%	-$8.3M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$828.2M+351.1%	$410.2M+88.0%	$466.6M+90.3%	$476.0M+74.3%	$183.6M-37.2%	$218.1M+15.9%	$245.1M+28.2%	$273.0M+91.8%
Current Assets	$775.8M+323.7%	$408.9M+87.9%	$465.7M+90.4%	$475.5M+74.5%	$183.1M-37.3%	$217.6M+16.0%	$244.6M+28.3%	$272.4M+92.2%
Cash & Equivalents	$182.0M+292.7%	$145.2M+781.1%	$165.7M+636.0%	$74.3M+489.1%	$46.4M+52.2%	$16.5M-47.2%	$22.5M-26.6%	$12.6M-51.1%
Short-Term Investments	$572.0M+368.7%	$241.9M+27.8%	$275.8M+29.7%	$380.7M+51.4%	$122.0M-51.7%	$189.2M+29.2%	$212.6M+41.8%	$251.5M+132.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$841.0M+504.1%	$356.6M+171.3%	$366.0M+182.6%	$359.0M+191.1%	$139.2M+20.2%	$131.5M+141.5%	$129.5M+151.7%	$123.3M+149.2%
Current Liabilities	$86.9M+117.5%	$33.2M+0.9%	$44.2M+39.2%	$38.8M+47.4%	$39.9M+104.5%	$32.9M+97.2%	$31.7M+123.6%	$26.3M+107.0%
Non-Current Liabilities	$754.1M+659.6%	$323.4M+228.2%	$321.9M+229.2%	$320.2M+230.1%	$99.3M+3.1%	$98.5M+161.0%	$97.8M+162.4%	$97.0M+163.8%
Long-Term Debt	$0-100.0%	$137.9M+30.9%	$137.5M+30.9%	$137.2M+30.9%	$105.6M+1.0%	$105.3M+177.0%	$105.1M+179.8%	$104.8M+182.6%
Total Equity	-$12.8M-128.8%	$53.5M-38.2%	$100.6M-13.0%	$117.0M-21.9%	$44.4M-74.9%	$86.7M-35.2%	$115.6M-17.3%	$149.7M+61.2%
Retained Earnings	-$580.6M-64.0%	-$501.7M-62.5%	-$448.9M-65.1%	-$397.9M-69.2%	-$354.1M-72.4%	-$308.9M-70.0%	-$271.9M-69.8%	-$235.2M-66.5%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

CELC Cash Flow Statement

CELC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Operating Cash Flow	-$191.7M	-$153.3M-83.6%	-$83.5M-55.1%	-$53.8M-49.4%	-$36.0M-77.3%	-$20.3M-184.3%	-$7.1M-19.1%	-$6.0M+1.3%	-$6.1M-22.8%	-$4.9M-71.3%	-$2.9M
Depreciation & Amortization	N/A	$167K+28.5%	$130K-10.5%	$145K-33.0%	$217K-29.9%	$309K-21.0%	$391K+13.5%	$345K+54.6%	$223K+113.0%	$105K+43.3%	$73K
Stock-Based Compensation	N/A	$21.4M+206.0%	$7.0M+42.6%	$4.9M+5.7%	$4.6M+77.7%	$2.6M+48.0%	$1.8M+69.4%	$1.0M-10.9%	$1.2M+33.6%	$874K+366.8%	$187K
Capital Expenditures	$450K	$249K-0.4%	$250K+156.0%	$98K-38.5%	$159K+93.9%	$82K-8.4%	$89K-76.5%	-$380K-39.6%	$630K+162.5%	$240K+486.4%	$41K
Free Cash Flow	-$192.2M	-$153.5M-83.4%	-$83.7M-55.3%	-$53.9M-49.1%	-$36.2M-77.3%	-$20.4M-181.9%	-$7.2M-13.4%	-$6.4M+4.9%	-$6.7M-29.3%	-$5.2M-77.1%	-$2.9M
Investing Cash Flow	-$450.3M	-$64.1M-1.6%	-$63.1M-1159.3%	-$5.0M+96.5%	-$144.0M-176847.6%	-$81K+8.9%	-$89K-101.0%	$8.5M-55.3%	$19.1M+165.9%	-$29.0M-70743.2%	-$41K
Financing Cash Flow	$777.7M	$360.6M+160.5%	$138.4M+113.2%	$64.9M-46.1%	$120.3M+29.3%	$93.0M+67336.7%	$138K-46.8%	$259K+9.6%	$237K-99.2%	$30.7M+725.9%	$3.7M
Dividends Paid	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$55.4M-53.1%	-$55.1M-53.6%	-$36.4M-31.1%	-$44.8M-118.0%	-$36.2M-100.4%	-$35.9M-110.1%	-$27.8M-49.8%	-$20.6M-61.3%
Depreciation & Amortization	$59K+47.5%	$47K+27.0%	$49K+40.0%	$41K+20.6%	$40K+29.0%	$37K+23.3%	$35K+25.2%	$34K+1.3%
Stock-Based Compensation	$6.9M+155.3%	$5.3M+117.9%	N/A	$6.8M+251.1%	$2.7M+91.6%	$2.4M+83.6%	N/A	$1.9M+74.2%
Capital Expenditures	$51K+30.8%	$249K+315.0%	$53K+17.8%	$97K+90.2%	$39K-39.1%	$60K-33.3%	$45K+37.6%	$51K-4.0%
Free Cash Flow	-$55.5M-53.0%	-$55.3M-54.0%	-$36.5M-31.1%	-$44.9M-117.9%	-$36.3M-99.9%	-$35.9M-109.3%	-$27.8M-49.8%	-$20.6M-61.0%
Investing Cash Flow	-$330.6M-602.0%	$34.5M+42.3%	$103.4M+175.3%	-$257.6M-13637.1%	$65.9M+162.1%	$24.3M+586.1%	$37.6M+191.1%	$1.9M-69.6%
Financing Cash Flow	$422.9M+182173.3%	$34K-99.4%	$24.4M+19770.7%	$330.3M+41036.4%	$232K-99.8%	$5.6M-60.6%	$123K-99.8%	$803K+5167.6%
Dividends Paid	N/A	N/A	N/A	$0	$0	$0	N/A	$0

Not reported in any period shown, so not listed: Share Buybacks.

CELC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CELC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Return on Equity	-176.1%-79.4pp	-96.7%-51.0pp	-45.6%-15.4pp	-30.2%+12.9pp	-43.1%+37.9pp	-81.0%-42.8pp	-38.1%-8.6pp	-29.5%-9.6pp	-19.9%+39.1pp	-59.0%
Return on Assets	-38.0%+7.7pp	-45.6%-12.3pp	-33.4%-10.4pp	-23.0%+11.5pp	-34.5%+38.7pp	-73.1%-36.8pp	-36.3%-7.6pp	-28.7%-9.2pp	-19.6%+35.1pp	-54.6%
Current Ratio	10.55+2.8x	7.71-5.7x	13.43-12.0x	25.46-8.6x	34.06+23.8x	10.26-10.9x	21.12-17.0x	38.07-4.3x	42.36+29.1x	13.27
Debt-to-Equity	1.37+0.5x	0.91+0.6x	0.270.0x	0.270.0x	0.23+0.1x	0.11+0.1x	0.050.0x	0.030.0x	0.02-0.1x	0.08

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Return on Equity	N/A	-98.7%-56.0pp	N/A	-37.5%-17.5pp	-102.0%-88.6pp	-42.7%-26.5pp	N/A	-19.9%-0.1pp
Return on Assets	-9.5%+15.1pp	-12.9%+4.1pp	N/A	-9.2%+1.7pp	-24.7%-16.6pp	-17.0%-5.5pp	N/A	-10.9%+2.0pp
Current Ratio	8.93+4.3x	12.31+5.7x	10.55+2.8x	12.26+1.9x	4.58-10.4x	6.61-4.6x	7.71-5.7x	10.36-0.8x
Debt-to-Equity	N/A	2.58+1.4x	1.37+0.5x	1.17+0.5x	2.38+1.8x	1.22+0.9x	0.91+0.6x	0.70+0.3x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Celcuity Inc. CELC	FY2025	N/A	-$177.0M	N/A	$3.1B	—
CG Oncology, Inc. CGON	FY2025	$4.0M	-$161.0M	N/A	$5.7B	61/100
Amicus Therapeutics, Inc FOLD	FY2025	$634.2M	-$27.1M	-4.3%	$4.5B	44/100
ImmunityBio, Inc. IBRX	FY2025	$113.3M	-$351.5M	N/A	$11.1B	41/100
Apogee Therapeutics, Inc. APGE	FY2025	N/A	-$255.8M	N/A	$10.2B	—
Travere Therapeutics, Inc. TVTX	FY2025	$490.7M	-$25.5M	-5.2%	$4.9B	71/100

Where Celcuity Inc. Ranks

Frequently Asked Questions

Is Celcuity Inc. profitable?

No, Celcuity Inc. (CELC) reported a net income of -$177.0M in fiscal year 2025.

What is Celcuity Inc.'s EBITDA?

Celcuity Inc. (CELC) had EBITDA of -$172.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Celcuity Inc. have?

As of fiscal year 2025, Celcuity Inc. (CELC) had $165.7M in cash and equivalents against $137.5M in long-term debt.

What is Celcuity Inc.'s return on equity (ROE)?

Celcuity Inc. (CELC) has a return on equity of -176.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Celcuity Inc.'s free cash flow?

Celcuity Inc. (CELC) recorded an outflow of $153.5M in free cash flow during fiscal year 2025. This represents a -83.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Celcuity Inc.'s operating cash flow?

Celcuity Inc. (CELC) recorded an outflow of $153.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Celcuity Inc.'s total assets?

Celcuity Inc. (CELC) had $466.6M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Celcuity Inc.'s capital expenditures?

Celcuity Inc. (CELC) invested $249K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Celcuity Inc. spend on research and development?

Celcuity Inc. (CELC) invested $145.0M in research and development during fiscal year 2025.

How many shares does Celcuity Inc. have outstanding?

Celcuity Inc. (CELC) had 48M shares outstanding as of fiscal year 2025.

What is Celcuity Inc.'s current ratio?

Celcuity Inc. (CELC) had a current ratio of 10.55 as of fiscal year 2025, which is generally considered healthy.

What is Celcuity Inc.'s debt-to-equity ratio?

Celcuity Inc. (CELC) had a debt-to-equity ratio of 1.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Celcuity Inc.'s return on assets (ROA)?

Celcuity Inc. (CELC) had a return on assets of -38.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Celcuity Inc.'s P/E ratio?

Celcuity Inc. (CELC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $3.1B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Celcuity Inc.'s price-to-sales ratio?

Celcuity Inc. (CELC) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $3.1B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Celcuity Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Celcuity Inc. (CELC) held $441.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $153.3M over that year. Dividing the one by the other, the reported balance equals about 35 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Celcuity Inc.'s Piotroski F-Score?

Celcuity Inc. (CELC) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Celcuity Inc.'s earnings high quality?

Celcuity Inc. (CELC) reported a net loss of $177.0M while operations used $153.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Celcuity Inc. cover its interest payments?

Celcuity Inc. (CELC) reported an operating loss of $172.2M against $14.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.